XML 43 R32.htm IDEA: XBRL DOCUMENT v3.25.3
STOCKHOLDERS’ EQUITY (Tables)
9 Months Ended
Sep. 30, 2025
Equity [Abstract]  
Schedule of black scholes option pricing model using assumptions
 Schedule of black scholes option pricing model using assumptions    
  

At

September 30, 2025

 
Grant date share price   $7.11 - $7.26 
Grant date exercise price   $5.64 - $6.17 
Expected term   0.25 years - 0.5 years 
Expected volatility   69.5% - 105.3%
Risk-free rate   4.02% - 4.32%
Expected dividend rate   0%
Schedule of stock-based compensation
     
   For the Nine Months ended
September 30, 2025
 
Cash payment received from employee withholding  $173,102 
Cash from employee withholdings used to purchase shares under ESPP   (114,724)
Accrued employee withholdings at September 30, 2025  $58,378 

 

     
   For the Nine Months ended
September 30, 2025
 
Cash from employee withholdings used to purchase ESPP shares  $114,724 
Stock based compensation expense   88,986 
Total increase to equity for nine months ended September 30, 2025  $203,710 

 

     
   For the Nine Months ended
September 30, 2024
 
Cash from employee withholdings used to purchase ESPP shares  $123,359 
Stock based compensation expense   54,833 

Total increase to equity for nine months ended September 30, 2024

  $178,192 
Schedule of options
 Schedule of options                 
    Number of
Options
   Weighted
Average
Exercise
Price
   Average
Remaining
Contractual
Term (Years)
   Aggregate
Intrinsic
Value
 
Outstanding at December 31, 2023    1,387,775   $5.23    3.0   $ 
Granted       $       $ 
Forfeited    (781,323)  $5.17       $ 
Outstanding at December 31, 2024    606,452   $5.29    2.0   $514,394 
Exercisable at December 31, 2024    442,445   $5.50    1.6   $296,145 
                      
Outstanding at December 31, 2024    606,452   $5.29    2.0   $514,394 
Granted    20,000   $5.64    4.5   $34,400 
Exercised/Forfeited/Expired    (141,327)  $5.31       $ 
Outstanding at September 30, 2025    485,125   $5.30    1.9   $997,153 
Exercisable at September 30, 2025    386,456   $5.51    1.6   $715,732 
Schedule of assumptions in determining the fair value of the warrants
        
    Upon Grant 
    Titan    Titan 
Date of Grant   August 1, 2025    September 2, 2025 
Stock Price  $6.57   $6.25 
Exercise Price  $7.20   $7.20 
Expected Remaining Term (Years)   5.00    5.00 
Historical Volatility   73%   55%
Expected Volatility   36%   33%
Dividend Yield   0%   0%
Annual Rate of Quarterly Dividends  $0.000   $0.000 
Discount Rate - Bond Equivalent Yield   3.770%   3.740%
Schedule of warrants
                 
   Number of
Warrants
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term (Years)
   Aggregate
Intrinsic
Value
 
Outstanding at December 31, 2023   44,644   $7.70    0.7   $ 
Warrants expired, forfeited, cancelled or exercised   (344,644)  $       $ 
Warrants issued   300,000   $3.00       $ 
Outstanding at December 31, 2024      $       $ 
Exercisable at December 31, 2024      $       $ 
                     
Outstanding at December 31, 2024      $       $ 
Warrants issued   375,276   $7.20    5.0   $ 
Warrants expired, forfeited, cancelled or exercised      $       $ 
Outstanding at September 30, 2025   375,276   $7.20    4.8   $60,044 
Exercisable at September 30, 2025   375,276   $7.20    4.8   $60,044 
Schedule of restricted stock unit
 Schedule of restricted stock unit        
   Number of
Shares
   Weighted
Average
Grant
Date Fair Value Per Share
 
Unvested at December 31, 2023     $  
Restricted stock forfeited     $  
Restricted stock granted     $  
Unvested at December 31, 2024     $  
Vested at December 31, 2024     $  
         
Unvested at December 31, 2024      $ 
Restricted stock granted   2,146,898   $6.13 
Restricted stock forfeited   (112,500)  $5.98 
Restricted stock vested   (20,000)  $5.22 
Unvested at September 30, 2025   2,014,398   $6.14 
Vested at September 30, 2025   20,000   $5.22